tiprankstipranks
Trending News
More News >
Novabay Pharmaceuticals (NBY)
:NBY
US Market

NovaBay Pharma (NBY) Income Statement

Compare
758 Followers

NovaBay Pharma Income Statement

Last quarter (Q3 2025), NovaBay Pharma's total revenue was $521.00K, a decrease of -78.66% from the same quarter last year. In Q3, NovaBay Pharma's net income was $-1.29M. See NovaBay Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 9.78M$ 10.46M$ 14.40M$ 10.20M$ 9.93M
Gross Profit
$ 6.48M$ 6.08M$ 7.78M$ 6.51M$ 5.96M
Operating Expenses
$ 12.32M$ 10.19M$ 22.20M$ 15.38M$ 12.39M
Depreciation and Amortization
$ 381.00K$ 356.00K$ 483.00K$ 119.00K$ 51.00K
EBITDA
$ -5.92M$ -4.09M$ -7.20M$ -8.74M$ -6.38M
Operating Income
$ -5.84M$ -4.10M$ -14.42M$ -8.86M$ -6.43M
Other Income/Expenses
$ -1.37M$ -2.04M$ 3.81M$ 3.04M$ -4.61M
Pretax Income
$ -7.21M$ -6.14M$ -10.61M$ -5.82M$ -11.03M
Net Income
$ -7.22M$ -9.64M$ -10.61M$ -5.82M$ -11.04M
Per Share Metrics
Basic EPS
$ -2.53$ -139.14$ -353.59$ -184.09$ -385.53
Diluted EPS
$ -2.53$ -138.65$ -353.59$ -184.09$ -385.53
Weighted Average Shares Outstanding
3.40M 120.00K 30.00K 31.64K 28.63K
Weighted Average Shares Outstanding (Diluted)
3.40M 120.00K 46.00K 35.63K 28.63K
Currency in USD

NovaBay Pharma Earnings and Revenue History